Navigation Links
Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
Date:11/7/2012

Research and Development at Biogen Idec.  He joined Biogen Idec from ZymoGenetics Inc., where he was most recently CEO and member of the Board of Directors. Previously, he held leadership positions within the biotechnology industry, including Chief Scientific Officer and Executive Vice President of Research and Development at Seattle Genetics Inc., and Senior Vice President and Washington Site Leader at Amgen Inc. Dr. Williams also served in a series of scientific and senior leadership positions over a decade at Immunex Corp., including Executive Vice President and Chief Technology Officer, Senior Vice President of Discovery Research and Vice President of Research and Development.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals (NASDAQ: ALNY) and Isis Pharmaceuticals (NASDAQ: ISIS). Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more information, please visit http://www.regulusrx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
2. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
3. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
4. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
5. Amarantus BioSciences Appoints Amgen Co-Founder Dr. Joseph Rubinfeld to Advisory Board
6. Aushon BioSystems Appoints Bill Williams Vice President of Sales
7. arGEN-X Appoints Dr. David L. Lacey to its Supervisory Board
8. Igenica Appoints Mary Haak-Frendscho, Ph.D., as Chief Executive Officer
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Circassia Appoints Stewart Sharpe as Vice President Commercial Operations
11. Pharmalink Consulting Appoints Chief Operating Officer for the Americas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  Smile Train and its ... showcase their Virtual Surgery Simulator among leading global health ... take place in Washington, D.C. ... Arts. "Smile Train is honored to ... talented community of innovators in health and medicine that ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, ... Tobago Ministry of Health approved the introduction of ... increases the cure rate from Hepatitis C, and ... genotype 1 virus. Telaprevir is available in ... INCIVO®. Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
(Date:7/25/2014)... MEXICO CITY , July 25, 2014 IBM ... Latin American healthcare sciences publisher, launched a library of ... conditions such as cancer and heart disease. Healthcare providers ... up-to-date information to deliver better patient care. ... with many relying on smartphones and tablets to access ...
Breaking Medicine Technology:Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 2Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 3Healthcare Sciences Publisher PLM and IBM Speed Access to Medical Information to Deliver Better Patient Care with Mobile 4
... at Leading Urology Meeting Show that Simple Urine Test ... Detection, Reduce Unnecessary Biopsies -- Gen-Probe to Begin Pivotal ... -SAN DIEGO, April 29 Eight studies presented this ... Association (AUA) suggest that Gen-Probe,s (Nasdaq: GPRO ...
... WASHINGTON, April 29 The recent announcement of the REDUCE ... Chicago brings optimism to the prostate cancer community as dutasteride ... shown to lower by 23 percent the risk of prostate ... Men,s Health Network looks forward to this becoming an additional ...
Cached Medicine Technology:Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 2Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 3Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 4Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 5Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer 2
(Date:7/26/2014)... WA (PRWEB) July 26, 2014 “Healthy teeth ... in keeping those pearly whites shining,” says Community Health Center ... Teeth Healthy ." , They believe that an integration of ... people healthy and well. Because of this, they encourage regular ... also with dentist . , “Children and adults will ...
(Date:7/26/2014)... July 26, 2014 Multiple sclerosis ... disseminata, is an inflammatory disease in which the ... and spinal cord are damaged. This damage disrupts ... to communicate, resulting in a wide range of ... psychiatric problems. Multiple sclerosis takes several forms, with ...
(Date:7/26/2014)... OH (PRWEB) July 26, 2014 The U.S. ... guidelines list that includes a new medication guide for AndroGel ... a serious side-effect of taking the topical low testosterone medication, ... that AbbVie Inc., the makers of the low testosterone theapy ... symptoms of pain, swelling or redness as signs of a ...
(Date:7/26/2014)... Louisville, Kentucky (PRWEB) July 26, 2014 ... concussions on the playing field; however, concussions ... on-the-job injuries. The occupations with the highest risk ... workers ,     Firefighters ,     Police officers ... dock workers ,     Delivery personnel ...
(Date:7/26/2014)... According to the Banish My Bumps ... comprehensive guide that covers detailed instructions on how to ... need of any medication. , Vkool reveals in ... safe remedies for relieving symptoms of keratosis pilaris quickly. ...     How to treat children's keratosis pilaris , ...
Breaking Medicine News(10 mins):Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 2Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 3Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3
... oral use of RU-486,s companion drug misoprostol is safe, but ... use of a drug given with RU-486 to terminate a ... infections seen in women taking the drugs since 2000, a ... drug misoprostol is FDA-approved to be taken by mouth along ...
... awarded to IDC in ... Pakistan, ... the global leader in the rapidly growing market for,digital radiography, today announced ... Pakistan to install the X-Series 2200,digital radiography (DR) systems in eight A-Class ...
... Clinica - the world,s leading news,service for the medical ... London,s Houses of Parliament have been at risk of ... during the,last three years. This news comes despite warnings ... Parliamentary assurances that the material,discovered in 2005 was safely ...
... Plan honored for service, strategic excellence by federal program, ... today,that the Blue Cross and Blue Shield Association has ... as well as to eight other,affiliated Blue plans., ... 2007 Best of,Blue FEP Plan Excellence winners at its ...
... showed similarities between lesbians, straight men , , MONDAY, June 16 ... remarkable similarities between the brains of gay men and straight ... For example, the brains of straight men and of gay ... the right hemisphere larger than the left, say the Swedish ...
... noninvasive molecular imaging technology, a method has been developed ... cells (MSCs) in the tumors of living organisms, according ... could lead to major advances in the use of ... cancer therapies are still in the early stages of ...
Cached Medicine News:Health News:Abortion drug's off-label use may have led to deaths 2Health News:Abortion drug's off-label use may have led to deaths 3Health News:IDC implements DR systems in eight A-Class military hospitals in Pakistan 2Health News:IDC implements DR systems in eight A-Class military hospitals in Pakistan 3Health News:Palace of Westminster Asbestos Problem Ignored 2Health News:Gay Men, Straight Women Have Similar Brains 2Health News:Gay Men, Straight Women Have Similar Brains 3Health News:Ability to track stem cells in tumors could advance cancer treatments 2Health News:Ability to track stem cells in tumors could advance cancer treatments 3
ASAT (GOT) FS (IFCC mod). For determination of ASAT (GOT) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
For the quantitative colorimetric determination of AST (SGOT) in serum....
For the quantitative determination of aspartate aminotransferase in serum. Optimized IFCC procedure without P-5'-P. 500 IU/L at 37C linearity....
... The stainer TST 44 is an ... needed in histology and cytology laboratories. It ... short time. Its again increased large number ... continuous working principle provides a high throughput. ...
Medicine Products: